MPD: All measures mapped to paradigm code 'series'

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Brinkmeyer1:173	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	perpendicular distance between centroids of either set of axial paws during peak stance as measured by DigiGait, post infection day 27 [cm] stance_width 64573 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:175	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stance width coefficient of variation as measured by DigiGait, post infection day 27 [%] stance_width_CV 64575 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:177	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	ratio of left and right stance durations as measured by DigiGait, post infection day 27 [ratio] stance_factor 64577 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:179	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stride width variability as measured by DigiGait, post infection day 27 [cm] stride_width_var 64579 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:181	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	angle made between left and right paws as a function of stride length and stance width as measured by DigiGait, post infection day 27 [deg] step_angle 64581 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:183	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	step angle variability (standard deviation of step angle for set of strides recorded) as measured by DigiGait, post infection day 27 [deg] step_angle_SD 64583 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:185	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	step angle coefficient of variation as measured by DigiGait, post infection day 27 [%] step_angle_CV 64585 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brown2:53	Brown2	visual water box	(none)	visual acuity, percent correct performance [%] pct_vis_acuit 22553 grating threshold: 0.17 (low) 0.32 0.64 (high)	inbred	14	both	10-18wks	N=7	2004

Brown2:57	Brown2	visual water box	(none)	latency to reach cued platform [s] vis_acuit 22557 grating threshold: 0.17 (low) 0.32 0.64 (high) overall mean	inbred	14	both	10-18wks	N=7	2004

Chesler3:81	Chesler3	monitoring system	(none)	percentage of time sleeping, baseline [%] pct_sleep 43581 total dark period	CC pre w/par	301	both	7-15wks	N=2	2011

Chesler3:83	Chesler3	monitoring system	(none)	percentage of time sleeping, after sleep deprivation [%] deprivation 43583 total dark period peak activity	CC pre w/par	301	both	7-15wks	N=2	2011

Crabbe4:2	Crabbe4	dowel balance test	ethanol	latency to fall, 0 min post-injection [s] latency_dowel0 19102 9.5mm 15.8mm	inbred	8	both	12-16wks	N=4	2003

Crabbe4:3	Crabbe4	dowel balance test	ethanol	latency to fall, 30 min post-injection [s] latency_dowel30 19103 9.5mm 15.8mm	inbred	8	both	12-16wks	N=4	2003

CSNA02:6	CSNA02	operant conditioning chamber	(none)	total number of trials in reversal learning needed to meet criteria [n] trials 62206 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA02:8	CSNA02	operant conditioning chamber	(none)	number of anticipatory nose pokes made in correct flanking hole during reversal learning [n] pokes_corr 62208 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA02:10	CSNA02	operant conditioning chamber	(none)	number of anticipatory nose pokes made in incorrect flanking hole during reversal learning [n] pokes_incorr 62210 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA02:12	CSNA02	operant conditioning chamber	(none)	omissions during reversal learning divided by total number of trials [n] omits 62212 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA02:14	CSNA02	operant conditioning chamber	(none)	latency to initiate trials divided by total number of trials [s] trial_latency 62214 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA02:16	CSNA02	operant conditioning chamber	(none)	latency to receive Boost divided by total number of trials [s] reward_latency 62216 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA03:452	CSNA03	operant conditioning chamber	cocaine	dose response, number of infusions (intravenous self administration), founders [n] infusions_in 110189 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	inbred w/CC8	8	both	4-25wks	N=14	2018

CSNA03:461	CSNA03	operant conditioning chamber	cocaine	dose response, number of infusions (intravenous self administration), CC [n] infusions_cc 110391 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	CC w/par	57	both	4-25wks	N=6	2018

CSNA03:470	CSNA03	operant conditioning chamber	cocaine	dose response, number of infusions (intravenous self administration), DO [n] infusions_do 110262 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	DO population w/par	9	both	4-25wks	N=73	2018

CSNA03:479	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), founders [n] extinction_active_in 110198 session: 1 2 3 4 5 6 7 8 9	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:488	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), CC [n] extinction_active_cc 110400 session: 1 2 3 4 5 6 7 8 9	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:497	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), DO [n] extinction_active_do 110271 session: 1 2 3 4 5 6 7 8 9	DO population w/par	8	both	4-25wks	N=39	2018

CSNA03:506	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), founders [n] extinction_inactive_in 110207 session: 1 2 3 4 5 6 7 8 9	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:515	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), CC [n] extinction_inactive_cc 110409 session: 1 2 3 4 5 6 7 8 9	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:524	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), DO [n] extinction_inactive_do 110280 session: 1 2 3 4 5 6 7 8 9	DO population w/par	8	both	4-25wks	N=39	2018

CSNA03:533	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), founders [n] reinstatement_active_in 110216 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:535	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), CC [n] reinstatement_active_cc 110418 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:537	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), DO [n] reinstatement_active_do 110289 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:540	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), founders [n] reinstatement_inactive_in 110218 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:542	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), CC [n] reinstatement_inactive_cc 110420 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:544	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), DO [n] reinstatement_inactive_do 110292 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:547	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), founders [n] reinstatement_inf_in 110220 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:549	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), CC [n] reinstatement_inf_cc 110422 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:551	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), DO [n] reinstatement_inf_do 110295 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:554	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), founders [n] days_criteria_in_JAX 110457 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:556	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), CC [n] days_criteria_cc_JAX 110487 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:558	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), DO [n] days_criteria_do_JAX 110517 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:560	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), founders [n] trials_in_JAX 110459 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:562	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), CC [n] trials_cc_JAX 110489 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:564	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), DO [n] trials_do_JAX 110519 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:569	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_JAX 110461 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:571	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_JAX 110491 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:573	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO [n] correct_do_JAX 110521 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:575	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_JAX 110463 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:577	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_JAX 110493 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:579	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO [n] omit_do_JAX 110523 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:581	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_JAX 110465 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:583	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_JAX 110495 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:585	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), DO [%] pct_correct_do_JAX 110525 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:587	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_JAX 110467 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:589	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_JAX 110497 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:591	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), DO [%] pct_omit_do_JAX 110527 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:593	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), founders [min] total_time_in_JAX 110469 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:595	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), CC [min] total_time_cc_JAX 110499 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:597	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), DO [min] total_time_do_JAX 110529 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:605	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_JAX 110473 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:607	CSNA03	operant conditioning chamber	(none)	mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_JAX 110503 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:609	CSNA03	operant conditioning chamber	(none)	mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO [centiseconds/n] trial_init_latency_do_JAX 110533 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:617	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), founders [centiseconds/n] reward_time_in_JAX 110477 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:619	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), CC [centiseconds/n] reward_time_cc_JAX 110507 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:621	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), DO [centiseconds/n] reward_time_do_JAX 110537 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:623	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_left_in_JAX 110479 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:625	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_left_cc_JAX 110509 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:627	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_left_do_JAX 110539 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:629	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_right_in_JAX 110481 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:631	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_right_cc_JAX 110511 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:633	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_right_do_JAX 110541 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:635	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_JAX 110483 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:637	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_JAX 110513 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:639	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_correct_do_JAX 110543 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:641	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_JAX 110485 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:643	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_JAX 110515 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:645	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_incorrect_do_JAX 110545 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:647	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), founders [n] trials_in_Binghamton 112873 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:649	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), CC [n] trials_cc_Binghamton 112891 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:653	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_Binghamton 112875 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:655	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_Binghamton 112893 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:657	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_Binghamton 112877 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:659	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_Binghamton 112895 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:661	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_Binghamton 112879 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:663	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_Binghamton 112897 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:665	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_Binghamton 112881 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:667	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_Binghamton 112899 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:669	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), founders [min] total_time_in_Binghamton 112883 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:671	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), CC [min] total_time_cc_Binghamton 112901 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:673	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_Binghamton 112885 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:675	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_Binghamton 112903 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:677	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_Binghamton 112887 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:679	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_Binghamton 112905 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:681	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_Binghamton 112889 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:683	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_Binghamton 112907 acquisition reversal	CC w/par	18	both		N=4	2021

Dickson1:1	Dickson1	operant conditioning chamber	(none)	goal-tracking [s] GTdur_all 54601 unpaired paired	inbred	5	both	12-20wks	N=5	2015

Dickson1:11	Dickson1	operant conditioning chamber	(none)	sign-tracking [s] STdur_all 54611 unpaired paired	inbred	5	both	12-20wks	N=5	2015

Evsikova1:16	Evsikova1	monitoring system	(none)	ambulatory activity (beam break triplets during 24h) [n] horiz 24716 daily light dark	inbred	14	both	26wks	N=7	2009

Evsikova1:26	Evsikova1	monitoring system	(none)	rearing activity (beam break triplets during 24h) [n] vert 24726 daily light dark	inbred	14	both	26wks	N=7	2009

Evsikova1:61	Evsikova1	intake monitoring	(none)	food intake [g] food 24761 daily light dark	inbred	14	both	26wks	N=6	2009

Evsikova1:76	Evsikova1	intake monitoring	(none)	water intake [mL] water 24776 daily light dark	inbred	14	both	26wks	N=7	2009

Flaherty1:5	Flaherty1	elevated zero maze	(none)	duration in open quadrants [s] open 11805 total q2 q4	inbred	8	both	8-9wks	N=20	2001

Flaherty1:6	Flaherty1	elevated zero maze	(none)	duration in closed quadrants [s] closed 11806 total q1 q3	inbred	8	both	8-9wks	N=20	2001

Flaherty1:13	Flaherty1	elevated zero maze	(none)	percentage of time in open quadrants [%] pct_open 11813 both q2 q4	inbred	8	both	8-9wks	N=20	2001

Flaherty1:14	Flaherty1	elevated zero maze	(none)	percentage of time in closed quadrants [%] pct_close 11814 q1 q3	inbred	8	both	8-9wks	N=20	2001

GMC05:11	GMC05	acoustic startle test	(none)	acoustic startle response (ASR) [amplitude] ASR 55411 background noise 70dB 80dB 85dB 90dB 100dB 110dB 120dB	inbred w/CC8	8	both	9-10wks	N=17	2018

GMC05:21	GMC05	acoustic startle test	(none)	acoustic startle response (ASR), 110 db sound pressure level [amplitude] ASR_PP 55421 67dB 69dB 73dB 81dB	inbred w/CC8	8	both	9-10wks	N=17	2018

GMC05:31	GMC05	acoustic startle test	(none)	percent prepulse inhibition (PPI), 110 db sound pressure level [%] PPI 55431 67dB 69dB 73dB 81dB	inbred w/CC8	8	both	9-10wks	N=17	2018

GMC05:41	GMC05	acoustic startle test	(none)	acoustic startle response (ASR) [amplitude] ASR_ISI 55441 inter-stimulus interval: 5 25 100	inbred w/CC8	8	both	9-10wks	N=17	2018

GMC05:51	GMC05	acoustic startle test	(none)	prepulse inhibition (PPI) [%] PPI_ISI 55451 inter-stimulus interval: 5 25 100	inbred w/CC8	8	both	9-10wks	N=17	2018

GMC12:31	GMC12	echocardiography	(none)	interventricular septum [mm] IVS 56131 diastole systole	inbred w/CC8	8	both	14-15wks	N=17	2018

GMC12:33	GMC12	echocardiography	(none)	left ventricular internal dimension [mm] LVID 56133 diastole systole	inbred w/CC8	8	both	14-15wks	N=17	2018

GMC12:35	GMC12	echocardiography	(none)	left ventricular posterior wall width [mm] LVPW 56135 diastole systole	inbred w/CC8	8	both	14-15wks	N=17	2018

GMC17:12	GMC17	ABR test	(none)	auditory brainstem response (ABR) threshold, sound pressure level [dB] pip 56612 6kHz 12 kHz 18 kHz 24 kHz 30 kHz	inbred w/CC7	7	both	17-18wks	N=13	2018

HMDPpheno4:1	HMDPpheno4	fear conditioning test	(none)	fear training, percent time spent near chamber walls, day1 [%] ftr_thig 46801 pre-stimulus post-stimulus	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:11	HMDPpheno4	fear conditioning test	(none)	fear training, velocity, day 1 [cm/s] ftr_vel 46811 pre-stimulus post-stimulus	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:21	HMDPpheno4	fear conditioning test	(none)	fear training, percent time immobile, day 1 [%] ftr_imob 46821 pre-stimulus post-stimulus	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:51	HMDPpheno4	fear conditioning test	(none)	cued fear thigmotaxis, percent time spent near chamber walls, day 3 [%] thig 46851 pre-cue cue	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:61	HMDPpheno4	fear conditioning test	(none)	cued fear, velocity, day 3 [cm/s] vel 46861 pre-cue cue	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:71	HMDPpheno4	fear conditioning test	(none)	cued fear, percent time immobile, day 3 [%] imob 46871 pre-cue cue	HMDP w/par	94	m	10wks	N=7	2011

JaxCC1:9047	JaxCC1	ABR test	(none)	auditory brainstem response (ABR) threshold, sound pressure level [dB] pip 89047 6kHz pip 12kHz pip 18kHz pip 24kHz pip 30kHz pip	CC	18	both	15-17wks	N=3	2017

JaxCC1:9062	JaxCC1	acoustic startle test	(none)	average acoustic startle response (ASR), adjusted for background noise [amplitude] ASR 89062 sound pressure level: 74dB 78dB 82dB 120dB	CC	18	both	9-11wks	N=7	2017

JaxCC1:9071	JaxCC1	acoustic startle test	(none)	average percent prepulse inhibition (PPI) evoked by 120 dB, adjusted for background noise [%] PPI 89071 prepulse stimulus: 74dB 78dB 82dB	CC	18	both	9-11wks	N=7	2017

JaxKOMP-EAP:148	JaxKOMP-EAP	hole board test	(none)	number of hole pokes by individual hole number, 20 min test [n] hole_pokes_by_hole total_hole_pokes_hole_N 100452 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16	KOMP	1484	both	10wks	N=8	2021

JaxKOMP-EAP:173	JaxKOMP-EAP	ABR test	(none)	auditory brainstem response (ABR) threshold, sound pressure level [dB] ABR minimum_threshold 100501 6 kHz pip 12 kHz pip 18 kHz pip 24 kHz pip 30 kHz pip	KOMP	1739	both	10wks	N=4	2021

JaxKOMP-EAP:180	JaxKOMP-EAP	acoustic startle test	(none)	average startle response to pre-pulse [mV] avg_pp ppN_avg 100509 pp1 pp2 pp3	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:184	JaxKOMP-EAP	acoustic startle test	(none)	average startle response to full pulse (120 dB) preceded by pre-pulse [mV] avg_pp_s ppN_s_avg 100510 pp1 pp2 pp3	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:187	JaxKOMP-EAP	acoustic startle test	(none)	average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_ppi pct_ppi_ppN_avg 100517 pp1 pp2 pp3	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:191	JaxKOMP-EAP	acoustic startle test	(none)	corrected average startle response to pre-pulse and full pulse (120 dB) minus average startle response to same pre-pulse [mV] avg_corrected_pp_s corrected_ppN_avg 100522 pp1 pp2 pp3	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:194	JaxKOMP-EAP	acoustic startle test	(none)	corrected average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_corrected_ppi corrected_percent_ppN_avg 100526 74 dB 78 dB 82 dB	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:199	JaxKOMP-EAP	acoustic startle test	(none)	maximum startle response to pre-pulse [mV] max_pp ppN 100533 pp1 pp2 pp3	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:203	JaxKOMP-EAP	acoustic startle test	(none)	maximum startle response to full pulse (120 dB) preceded by pre-pulse [mV] max_pp_s ppN_s 100537 74 dB 78 dB 82 dB	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:206	JaxKOMP-EAP	acoustic startle test	(none)	maximum percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] max_ppi pct_ppi_ppN 100540 pp2 pp3	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:211	JaxKOMP-EAP	acoustic startle test	(none)	corrected maximum startle response to pre-pulse and full pulse (120 dB) minus maximum startle response to same pre-pulse [mV] max_corrected_pp_s corrected_ppN_vmax 100551 pp1 pp2 pp3	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:214	JaxKOMP-EAP	acoustic startle test	(none)	corrected maximum percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] max_corrected_ppi corrected_percent_ppN_vmax 100555 pp1 pp2 pp3	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:399	JaxKOMP-EAP	electroconvulsion test	(none)	applied stimulus (current), by day [mA] current ma 100783 day: 1 2 3 4 5 6 7 8 9 10	KOMP	23	both	17wks	N=8	2016

JaxKOMP-EAP:409	JaxKOMP-EAP	electroconvulsion test	(none)	behavior following applied stimulus (current), by day [score] score 100784 day: 1 2 3 4 5 6 7 8 9 10	KOMP	448	both	17wks	N=9	2016

JaxKOMP-LAP:143	JaxKOMP-LAP	hole board test	(none)	number of hole pokes by individual hole number, 20 min test [n] total_hole_pokes_hole_N 101452 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16	KOMP	97	both	67-73wks	N=7	2021

JaxKOMP-LAP:169	JaxKOMP-LAP	acoustic startle test	(none)	average startle response to pre-pulse [mV] avg_pp ppN_avg 101509 pp1 pp2 pp3	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:173	JaxKOMP-LAP	acoustic startle test	(none)	average startle response to full pulse (120 dB) preceded by pre-pulse [mV] avg_pp_s ppN_s_avg 101510 pp1 pp2 pp3	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:176	JaxKOMP-LAP	acoustic startle test	(none)	average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_ppi pct_ppi_ppN_avg 101517 pp1 pp2 pp3	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:180	JaxKOMP-LAP	acoustic startle test	(none)	corrected average startle response to pre-pulse and full pulse (120 dB) minus average startle response to same pre-pulse [mV] avg_corrected_pp_s corrected_ppN_avg 101522 pp1 pp2 pp3	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:183	JaxKOMP-LAP	acoustic startle test	(none)	corrected average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_corrected_ppi corrected_percent_ppN_avg 101526 74 dB 78 dB 82 dB	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:188	JaxKOMP-LAP	acoustic startle test	(none)	maximum startle response to pre-pulse [mV] max_pp ppN 101533 pp1 pp2 pp3	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:192	JaxKOMP-LAP	acoustic startle test	(none)	maximum startle response to full pulse (120 dB) preceded by pre-pulse [mV] max_pp_s ppN_s 101537 74 dB 78 dB 82 dB	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:195	JaxKOMP-LAP	acoustic startle test	(none)	maximum percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] max_ppi pct_ppi_ppN 101540	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:198	JaxKOMP-LAP	acoustic startle test	(none)	corrected maximum startle response to pre-pulse and full pulse (120 dB) minus maximum startle response to same pre-pulse [mV] max_corrected_pp_s corrected_ppN_vmax 101551 pp1 pp2 pp3	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:201	JaxKOMP-LAP	acoustic startle test	(none)	corrected maximum percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] max_corrected_ppi corrected_percent_ppN_vmax 101555 pp1 pp2 pp3	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:283	JaxKOMP-LAP	ABR test	(none)	auditory brainstem response (ABR) threshold, sound pressure level [dB] pip minimum_threshold 101501 6 kHz pip 12 kHz pip 18 kHz pip 24 kHz pip 30 kHz pip	KOMP		both	74-78wks	N=4	2017

Jaxpheno8:1	Jaxpheno8	ABR test	(none)	auditory brainstem response (ABR) threshold, sound pressure level [dB] ABR 35001 click 8kHz tone 16kHz tone 32kHz tone	inbred	7	m	10-13wks	N=9	2010

Jaxpheno8:17	Jaxpheno8	echocardiography	(none)	interventricular septum thickness [mm] IVS 35017 diastolic systolic	inbred	6	m	12wks	N=5	2010

Jaxpheno8:19	Jaxpheno8	echocardiography	(none)	left ventricle anterior wall thickness [mm] LV_AW 35019 diastolic systolic	inbred	6	m	12wks	N=5	2010

Jaxpheno8:21	Jaxpheno8	echocardiography	(none)	left ventricle posterior wall thickness [mm] LV_PW 35021 diastolic systolic	inbred	6	m	12wks	N=5	2010

Jaxpheno8:23	Jaxpheno8	echocardiography	(none)	left ventricle internal dimension [mm] LVID 35023 diastolic systolic	inbred	6	m	12wks	N=5	2010

Jaxpheno8:25	Jaxpheno8	echocardiography	(none)	left ventricle volume [µL] LV_vol 35025 diastolic systolic	inbred	6	m	12wks	N=5	2010

Johnson1:2	Johnson1	ABR test	(none)	auditory brainstem response (ABR) threshold, 3-12 wk old group, sound pressure level [dB] pip_yng 1402 click 8kHz pip 16kHz pip 32kHz pip	inbred	42	both	3-12wks	N=7	2000

Johnson1:7	Johnson1	ABR test	(none)	auditory brainstem response (ABR) threshold, 15-72 wk old group, sound pressure level [dB] pip_old 1407 click 8kHz pip 16kHz pip 32kHz pip	inbred	27	both	15-72wks	N=12	2000

Johnson3:1	Johnson3	ABR test	(none)	auditory brainstem response (ABR) threshold, sound pressure level [dB] ABR 42501 click 8kHZ tone 16kHz tone 32kHz tone	B6.A consomic w/par	24	both	23-30wks	N=7	2012

Johnson4:1	Johnson4	ABR test	(none)	auditory brainstem response (ABR) threshold, sound pressure level [dB] ABR 42601 click 8kHZ tone 16kHz tone 32kHz tone	B6.PWD consomic w/par	28	both	49-63wks	N=8	2012

Kumar2:1	Kumar2	open field test	(none)	distance traveled, 55 min test [cm] distance 65001 first 10 min total	inbred	58	both	7-26wks	N=16	2019

Loos2:1	Loos2	home cage monitoring	(none)	cumulative number of activity bouts, over 3 days of testing, log10 transformed [log(n)] activity_num 54001 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:5	Loos2	home cage monitoring	(none)	mean duration per activity bout, over 3 days of testing, log10 transformed [log(s)] activity_mean_dur 54005 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:7	Loos2	home cage monitoring	(none)	habituation ratio describing change in cumulative activity duration, over 3 days of testing, log10 transformed [log(ratio)] activity_dur_hab 54007 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:12	Loos2	home cage monitoring	(none)	cumulative duration in spout zone, over 3 days of testing, log10 transformed [log(s)] spout_dur 54012	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:16	Loos2	home cage monitoring	(none)	cumulative number of visits to OnShelter zone, over 3 days of testing, log10 transformed [log(n)] onshelter_num 54016 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:18	Loos2	home cage monitoring	(none)	cumulative duration in OnShelter zone, over 3 days of testing, log10 transformed [log(s)] onshelter_dur 54018 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:22	Loos2	home cage monitoring	(none)	change in activity proportion: anticipation of phase change, over 3 days of testing activity_anticipation 54022 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:24	Loos2	home cage monitoring	(none)	change in activity proportion: response to phase onset, over 3 days of testing activity_response 54024 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:26	Loos2	home cage monitoring	(none)	change in Spout zone duration: anticipation of phase change, over 3 days of testing spout_anticipation 54026 dark light	inbred w/CC7	11	m	8-12wks	N=35	2016

Loos2:28	Loos2	home cage monitoring	(none)	change in Spout zone duration: response to phase onset, over 3 days of testing spout_response 54028 dark light	inbred w/CC7	11	m	8-12wks	N=36	2016

Loos2:32	Loos2	home cage monitoring	(none)	change in Feeding zone duration: anticipation of phase change, over 3 days of testing feeding_anticipation 54032 dark light	inbred w/CC7	11	m	8-12wks	N=35	2016

Loos2:34	Loos2	home cage monitoring	(none)	change in Feeding zone duration: response to phase onset, over 3 days of testing feeding_response 54034 dark light	inbred w/CC7	11	m	8-12wks	N=36	2016

Loos2:36	Loos2	home cage monitoring	(none)	change in OnShelter zone duration: anticipation of phase change, over 3 days of testing onshelter_anticipation 54036 dark light	inbred w/CC7	11	m	8-12wks	N=35	2016

Loos2:38	Loos2	home cage monitoring	(none)	change in OnShelter zone duration: response to phase onset, over 3 days of testing onshelter_response 54038 dark light	inbred w/CC7	11	m	8-12wks	N=36	2016

Loos2:42	Loos2	home cage monitoring	(none)	cumulative long movement number, over 3 days of testing, log10 transformed [log(n)] long_move_num 54042 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:44	Loos2	home cage monitoring	(none)	cumulative long movement distance, over 3 days of testing, log10 transformed [log(cm)] long_move_dist 54044 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:48	Loos2	home cage monitoring	(none)	cumulative short movement number, over 3 days of testing, log10 transformed [log(n)] short_move_num 54048 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:52	Loos2	home cage monitoring	(none)	cumulative short movement distance, over 3 days of testing, log10 transformed [log(cm)] short_move_dist 54052 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:54	Loos2	home cage monitoring	(none)	cumulative number of long arrests, over 3 days of testing, log10 transformed [log(n)] long_arrest_num 54054 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:58	Loos2	home cage monitoring	(none)	mean duration per long arrest, over 3 days of testing, log10 transformed [log(s)] long_arrest_dur_mean 54058 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:63	Loos2	home cage monitoring	(none)	cumulative number of short arrests, over 3 days of testing, log10 transformed [log(n)] short_arrest_num 54063 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:67	Loos2	home cage monitoring	(none)	mean duration per short arrest, over 3 days of testing, log10 transformed [log(s)] short_arrest_dur_mean 54067 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:71	Loos2	home cage monitoring	(none)	cumulative number of long shelter visits (sheltering), over 3 days of testing, log10 transformed [log(n)] long_shelter_num 54071 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:73	Loos2	home cage monitoring	(none)	cumulative duration of long shelter visits (sheltering), over 3 days of testing [s] long_shelter_dur 54073 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:77	Loos2	home cage monitoring	(none)	cumulative number of short shelter visits (sheltering), over 3 days of testing, log10 transformed [log(n)] short_shelter_num 54077 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Molenhuis1:2	Molenhuis1	monitoring system	(none)	social discrimination capacity (preference for novel versus familiar conspecific mouse) [ratio] discrimination 110069 short term discrimination long term discrimination	CC	49	m	7-20wks	N=4	2018

Petryshen1:1	Petryshen1	acoustic startle test	(none)	acoustic startle response (ASR) without prepulse stimulus presented [N] ASR nostim 34701 no tone 120dB tone	B6.A consomic	22	m	7-9wks	N=23	2009

Petryshen1:3	Petryshen1	acoustic startle test	(none)	acoustic startle response (ASR) evoked by 120 dB tone [N] ASR 34703 70dB 75dB 80dB 85dB	B6.A consomic	22	m	7-9wks	N=23	2009

Petryshen1:7	Petryshen1	acoustic startle test	(none)	percent prepulse inhibition (PPI) evoked by 120 dB tone [%] PPI 34707 70dB 75dB 80dB 85dB	B6.A consomic	22	m	7-9wks	N=23	2009

Seburn1:8	Seburn1	monitoring system	(none)	oxygen volume, 3 day test [mL/kg/h] VO2 9208 daily light dark	inbred	16	both	7-9wks	N=8	2001

Seburn1:11	Seburn1	monitoring system	(none)	carbon dioxide volume, 3 day test [mL/kg/h] VCO2 9211 daily light dark	inbred	16	both	7-9wks	N=8	2001

Seburn1:14	Seburn1	monitoring system	(none)	respiratory exchange ratio, 3 day test [ratio] RER 9214 daily light dark	inbred	16	both	7-9wks	N=8	2001

Seburn1:17	Seburn1	monitoring system	(none)	body heat production, 3 day test [kcal/h] heat 9217 daily light dark	inbred	16	both	7-9wks	N=8	2001

Seburn1:23	Seburn1	monitoring system	(none)	total activity, beam breaks per min, 3 day test [n/min] tot 9223 daily light dark	inbred	16	both	7-9wks	N=8	2001

Seburn1:26	Seburn1	monitoring system	(none)	ambulatory activity, beam breaks per min, 3 day test [n/min] aa 9226 daily light dark	inbred	16	both	7-9wks	N=8	2001

Seburn1:29	Seburn1	monitoring system	(none)	rearing activity, beam breaks per min, 3 day test [n/min] ra 9229 daily light dark	inbred	16	both	7-9wks	N=8	2001

Spijker1:1	Spijker1	acoustic startle test	(none)	acoustic startle response (ASR) [amplitude] ASR 40601 65dB 70dB 75dB 80dB 90dB 100dB 110dB 120dB	BXD w/par	39	m	8wks	N=11	2011

Spijker1:13	Spijker1	acoustic startle test	(none)	prepulse inhibition (PPI), 120 dB startle intensity [%] PPI 40613 120 dB startle intensity with prepulse stimulus: 65dB 70dB 75dB 80dB	BXD w/par	36	m	8wks	N=9	2011

Tordoff1:3	Tordoff1	bottle choice test	(none)	preference for NaCl (sodium chloride) solutions [%] NaCl_pref 6103 concentration (mM): 75 150 300 450	inbred	28	m	4-12wks	N=11	2001

Tordoff1:9	Tordoff1	bottle choice test	(none)	preference for KCl (potassium chloride) solutions [%] KCl_pref 6109 concentration (mM): 10 30 100 200 300	inbred	28	m	4-12wks	N=12	2001

Tordoff1:16	Tordoff1	bottle choice test	(none)	preference for CaCl2 (calcium chloride) solutions [%] CaCl2_pref 6116 concentration (mM): 3 10 30 100	inbred	28	m	4-12wks	N=11	2001

Tordoff1:22	Tordoff1	bottle choice test	(none)	preference for NH4Cl (ammonium chloride) solutions [%] NH4Cl_pref 6122 concentration (mM): 10 30 100 300	inbred	28	m	4-12wks	N=11	2001

Tordoff3:5	Tordoff3	body weight	(none)	body weight [g] bw 10305 start end fold change	inbred w/CC7	40	both	8-10wks	N=10	2002

Tordoff3:8	Tordoff3	bottle choice test	(none)	preference for CaCl2 (calcium chloride) solutions [%] CaCl2_pref 10308 concentration (mM): 7.5 25 75	inbred w/CC7	40	both	9-11wks	N=10	2002

Tordoff3:11	Tordoff3	bottle choice test	(none)	preference for CaLa (calcium lactate) solutions [%] CaLa_pref 10311 concentration (mM): 7.5 25 75	inbred w/CC7	40	both	10-12wks	N=10	2002

Tordoff3:14	Tordoff3	bottle choice test	(none)	preference for NaCl (sodium chloride) solutions [%] NaCl_pref 10314 concentration (mM): 25 75 225	inbred w/CC7	40	both	11-13wks	N=10	2002

Tordoff3:17	Tordoff3	bottle choice test	(none)	preference for NaLa (sodium lactate) solutions [%] NaLa_pref 10317 concentration (mM): 25 75 225	inbred w/CC7	40	both	12-14wks	N=10	2002

Trullas1:21	Trullas1	open field test	(none)	distance traveled, 5 min test [cm] OF_dist 52821 dim lights bright lights ratio	inbred	10	m	6-8wks	N=8	1993

Trullas1:22	Trullas1	open field test	(none)	amount of time moving horizontally, 5 min test [s] OF_horiz 52822 dim lights bright lights ratio	inbred	10	m	6-8wks	N=8	1993

Trullas1:23	Trullas1	open field test	(none)	number of times rearing, 5 min test [n] OF_rear 52823 dim lights bright lights ratio	inbred	10	m	6-8wks	N=8	1993

Willott1:2	Willott1	acoustic startle test	(none)	acoustic startle response (ASR) [amplitude] ASR 9102 sound pressure level: 70dB 80dB 90dB 100dB	inbred w/CC7	40	both	5-6wks	N=10	2002

Willott1:8	Willott1	acoustic startle test	(none)	mean prepulse inhibition (PPI), 70dB [ratio] PPI 9108 4kHz 12kHz 20kHz all tones	inbred w/CC7	40	both	5-6wks	N=10	2002

Xenakis2:181	Xenakis2	intake monitoring	arsenic	water consumption [g] water 118335 iAs: 4 to 2 wks before 2 wks before to start start to 1 wk after 1 to 2 wks after (12 more)...	DO population		m	4-34wks	N=74	2022

Xenakis2:197	Xenakis2	MRI	arsenic	weight of fat tissue [g] fat_wt 118351 iAs: 2 wks before 12 wks after 24 wks after	DO population		m	6-32wks	N=74	2022

Xenakis2:209	Xenakis2	urinalysis	arsenic	urine volume, 2 wks before iAs [μL] urine_2wksBef 118363 attempt: 1st 2nd 3rd	DO population		m	6wks	N=45	2022

Xenakis2:212	Xenakis2	urinalysis	arsenic	urine volume, 12 wks after iAs [μL] urine_12wks 118366 attempt: 1st 2nd 3rd	DO population		m	20wks	N=25	2022

Zimmermann1:5	Zimmermann1	intake monitoring	(none)	food consumption, second day [g] food_intake 112168 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:7	Zimmermann1	intake monitoring	(none)	water consumption, second day [mL] water_intake 112170 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:9	Zimmermann1	monitoring system	(none)	fine or stationary movement on x-y axis, repeated interruptions of same beam, second day (beam breaks/min) [n/min] fine_act 112172 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:11	Zimmermann1	monitoring system	(none)	ambulatory movement on x-y axis, consecutive interruptions of different beams, second day (beam breaks/min) [n/min] amb_act 112174 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:13	Zimmermann1	monitoring system	(none)	rearing movement, number of z-axis beam breaks, second day (beam breaks/min) [n/min] rearing_act 112176 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:15	Zimmermann1	monitoring system	(none)	respiratory exchange ratio (VCO2:VO2), second day [ratio] rer 112178 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:17	Zimmermann1	monitoring system	(none)	volume of oxygen consumed, second day [mL/h] vo2 112180 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:19	Zimmermann1	monitoring system	(none)	volume of carbon dioxide produced, second day [mL/h] vco2 112182 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:21	Zimmermann1	monitoring system	(none)	energy expenditure, second day [kcal/h] energy 112184 during light during dark	inbred	30	both	7-15wks	N=11	2020

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

perpendicular distance between centroids of either set of axial paws during peak stance as measured by DigiGait, post infection day 27 [cm] stance_width 64573 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stance width coefficient of variation as measured by DigiGait, post infection day 27 [%] stance_width_CV 64575 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

ratio of left and right stance durations as measured by DigiGait, post infection day 27 [ratio] stance_factor 64577 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stride width variability as measured by DigiGait, post infection day 27 [cm] stride_width_var 64579 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

angle made between left and right paws as a function of stride length and stance width as measured by DigiGait, post infection day 27 [deg] step_angle 64581 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

step angle variability (standard deviation of step angle for set of strides recorded) as measured by DigiGait, post infection day 27 [deg] step_angle_SD 64583 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

step angle coefficient of variation as measured by DigiGait, post infection day 27 [%] step_angle_CV 64585 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brown2

visual water box

(none)

visual acuity, percent correct performance [%] pct_vis_acuit 22553 grating threshold: 0.17 (low) 0.32 0.64 (high)

inbred

14

both

10-18wks

N=7

2004

Brown2

visual water box

(none)

latency to reach cued platform [s] vis_acuit 22557 grating threshold: 0.17 (low) 0.32 0.64 (high) overall mean

inbred

14

both

10-18wks

N=7

2004

Chesler3

monitoring system

(none)

percentage of time sleeping, baseline [%] pct_sleep 43581 total dark period

CC pre w/par

301

both

7-15wks

N=2

2011

Chesler3

monitoring system

(none)

percentage of time sleeping, after sleep deprivation [%] deprivation 43583 total dark period peak activity

CC pre w/par

301

both

7-15wks

N=2

2011

Crabbe4

dowel balance test

ethanol

latency to fall, 0 min post-injection [s] latency_dowel0 19102 9.5mm 15.8mm

inbred

8

both

12-16wks

N=4

2003

Crabbe4

dowel balance test

ethanol

latency to fall, 30 min post-injection [s] latency_dowel30 19103 9.5mm 15.8mm

inbred

8

both

12-16wks

N=4

2003

CSNA02

operant conditioning chamber

(none)

total number of trials in reversal learning needed to meet criteria [n] trials 62206 acquisition reversal

inbred

10

both

12-14wks

N=5

2018

CSNA02

operant conditioning chamber

(none)

number of anticipatory nose pokes made in correct flanking hole during reversal learning [n] pokes_corr 62208 acquisition reversal

inbred

10

both

12-14wks

N=5

2018

CSNA02

operant conditioning chamber

(none)

number of anticipatory nose pokes made in incorrect flanking hole during reversal learning [n] pokes_incorr 62210 acquisition reversal

inbred

10

both

12-14wks

N=5

2018

CSNA02

operant conditioning chamber

(none)

omissions during reversal learning divided by total number of trials [n] omits 62212 acquisition reversal

inbred

10

both

12-14wks

N=5

2018

CSNA02

operant conditioning chamber

(none)

latency to initiate trials divided by total number of trials [s] trial_latency 62214 acquisition reversal

inbred

10

both

12-14wks

N=5

2018

CSNA02

operant conditioning chamber

(none)

latency to receive Boost divided by total number of trials [s] reward_latency 62216 acquisition reversal

inbred

10

both

12-14wks

N=5

2018

CSNA03

operant conditioning chamber

cocaine

dose response, number of infusions (intravenous self administration), founders [n] infusions_in 110189 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

inbred w/CC8

8

both

4-25wks

N=14

2018

CSNA03

operant conditioning chamber

cocaine

dose response, number of infusions (intravenous self administration), CC [n] infusions_cc 110391 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

CC w/par

57

both

4-25wks

N=6

2018

CSNA03

operant conditioning chamber

cocaine

dose response, number of infusions (intravenous self administration), DO [n] infusions_do 110262 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

DO population w/par

9

both

4-25wks

N=73

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), founders [n] extinction_active_in 110198 session: 1 2 3 4 5 6 7 8 9

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), CC [n] extinction_active_cc 110400 session: 1 2 3 4 5 6 7 8 9

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), DO [n] extinction_active_do 110271 session: 1 2 3 4 5 6 7 8 9

DO population w/par

8

both

4-25wks

N=39

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), founders [n] extinction_inactive_in 110207 session: 1 2 3 4 5 6 7 8 9

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), CC [n] extinction_inactive_cc 110409 session: 1 2 3 4 5 6 7 8 9

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), DO [n] extinction_inactive_do 110280 session: 1 2 3 4 5 6 7 8 9

DO population w/par

8

both

4-25wks

N=39

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), founders [n] reinstatement_active_in 110216 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), CC [n] reinstatement_active_cc 110418 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), DO [n] reinstatement_active_do 110289 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), founders [n] reinstatement_inactive_in 110218 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), CC [n] reinstatement_inactive_cc 110420 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), DO [n] reinstatement_inactive_do 110292 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), founders [n] reinstatement_inf_in 110220 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), CC [n] reinstatement_inf_cc 110422 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), DO [n] reinstatement_inf_do 110295 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), founders [n] days_criteria_in_JAX 110457 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), CC [n] days_criteria_cc_JAX 110487 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), DO [n] days_criteria_do_JAX 110517 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), founders [n] trials_in_JAX 110459 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), CC [n] trials_cc_JAX 110489 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), DO [n] trials_do_JAX 110519 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_JAX 110461 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_JAX 110491 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO [n] correct_do_JAX 110521 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_JAX 110463 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_JAX 110493 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO [n] omit_do_JAX 110523 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_JAX 110465 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_JAX 110495 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), DO [%] pct_correct_do_JAX 110525 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_JAX 110467 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_JAX 110497 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), DO [%] pct_omit_do_JAX 110527 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), founders [min] total_time_in_JAX 110469 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), CC [min] total_time_cc_JAX 110499 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), DO [min] total_time_do_JAX 110529 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_JAX 110473 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_JAX 110503 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO [centiseconds/n] trial_init_latency_do_JAX 110533 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), founders [centiseconds/n] reward_time_in_JAX 110477 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), CC [centiseconds/n] reward_time_cc_JAX 110507 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), DO [centiseconds/n] reward_time_do_JAX 110537 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_left_in_JAX 110479 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_left_cc_JAX 110509 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_left_do_JAX 110539 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_right_in_JAX 110481 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_right_cc_JAX 110511 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_right_do_JAX 110541 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_JAX 110483 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_JAX 110513 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_correct_do_JAX 110543 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_JAX 110485 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_JAX 110515 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_incorrect_do_JAX 110545 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), founders [n] trials_in_Binghamton 112873 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), CC [n] trials_cc_Binghamton 112891 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_Binghamton 112875 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_Binghamton 112893 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_Binghamton 112877 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_Binghamton 112895 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_Binghamton 112879 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_Binghamton 112897 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_Binghamton 112881 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_Binghamton 112899 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), founders [min] total_time_in_Binghamton 112883 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), CC [min] total_time_cc_Binghamton 112901 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_Binghamton 112885 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_Binghamton 112903 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_Binghamton 112887 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_Binghamton 112905 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_Binghamton 112889 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_Binghamton 112907 acquisition reversal

CC w/par

18

both

N=4

2021

Dickson1

operant conditioning chamber

(none)

goal-tracking [s] GTdur_all 54601 unpaired paired

inbred

5

both

12-20wks

N=5

2015

Dickson1

operant conditioning chamber

(none)

sign-tracking [s] STdur_all 54611 unpaired paired

inbred

5

both

12-20wks

N=5

2015

Evsikova1

monitoring system

(none)

ambulatory activity (beam break triplets during 24h) [n] horiz 24716 daily light dark

inbred

14

both

26wks

N=7

2009

Evsikova1

monitoring system

(none)

rearing activity (beam break triplets during 24h) [n] vert 24726 daily light dark

inbred

14

both

26wks

N=7

2009

Evsikova1

intake monitoring

(none)

food intake [g] food 24761 daily light dark

inbred

14

both

26wks

N=6

2009

Evsikova1

intake monitoring

(none)

water intake [mL] water 24776 daily light dark

inbred

14

both

26wks

N=7

2009

Flaherty1

elevated zero maze

(none)

duration in open quadrants [s] open 11805 total q2 q4

inbred

8

both

8-9wks

N=20

2001

Flaherty1

elevated zero maze

(none)

duration in closed quadrants [s] closed 11806 total q1 q3

inbred

8

both

8-9wks

N=20

2001

Flaherty1

elevated zero maze

(none)

percentage of time in open quadrants [%] pct_open 11813 both q2 q4

inbred

8

both

8-9wks

N=20

2001

Flaherty1

elevated zero maze

(none)

percentage of time in closed quadrants [%] pct_close 11814 q1 q3

inbred

8

both

8-9wks

N=20

2001

GMC05

acoustic startle test

(none)

acoustic startle response (ASR) [amplitude] ASR 55411 background noise 70dB 80dB 85dB 90dB 100dB 110dB 120dB

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC05

acoustic startle test

(none)

acoustic startle response (ASR), 110 db sound pressure level [amplitude] ASR_PP 55421 67dB 69dB 73dB 81dB

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC05

acoustic startle test

(none)

percent prepulse inhibition (PPI), 110 db sound pressure level [%] PPI 55431 67dB 69dB 73dB 81dB

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC05

acoustic startle test

(none)

acoustic startle response (ASR) [amplitude] ASR_ISI 55441 inter-stimulus interval: 5 25 100

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC05

acoustic startle test

(none)

prepulse inhibition (PPI) [%] PPI_ISI 55451 inter-stimulus interval: 5 25 100

inbred w/CC8

8

both

9-10wks

N=17

2018

GMC12

echocardiography

(none)

interventricular septum [mm] IVS 56131 diastole systole

inbred w/CC8

8

both

14-15wks

N=17

2018

GMC12

echocardiography

(none)

left ventricular internal dimension [mm] LVID 56133 diastole systole

inbred w/CC8

8

both

14-15wks

N=17

2018

GMC12

echocardiography

(none)

left ventricular posterior wall width [mm] LVPW 56135 diastole systole

inbred w/CC8

8

both

14-15wks

N=17

2018

GMC17

ABR test

(none)

auditory brainstem response (ABR) threshold, sound pressure level [dB] pip 56612 6kHz 12 kHz 18 kHz 24 kHz 30 kHz

inbred w/CC7

7

both

17-18wks

N=13

2018

HMDPpheno4

fear conditioning test

(none)

fear training, percent time spent near chamber walls, day1 [%] ftr_thig 46801 pre-stimulus post-stimulus

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

fear training, velocity, day 1 [cm/s] ftr_vel 46811 pre-stimulus post-stimulus

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

fear training, percent time immobile, day 1 [%] ftr_imob 46821 pre-stimulus post-stimulus

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

cued fear thigmotaxis, percent time spent near chamber walls, day 3 [%] thig 46851 pre-cue cue

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

cued fear, velocity, day 3 [cm/s] vel 46861 pre-cue cue

HMDP w/par

94

m

10wks

N=7

2011

HMDPpheno4

fear conditioning test

(none)

cued fear, percent time immobile, day 3 [%] imob 46871 pre-cue cue

HMDP w/par

94

m

10wks

N=7

2011

JaxCC1

ABR test

(none)

auditory brainstem response (ABR) threshold, sound pressure level [dB] pip 89047 6kHz pip 12kHz pip 18kHz pip 24kHz pip 30kHz pip

CC

18

both

15-17wks

N=3

2017

JaxCC1

acoustic startle test

(none)

average acoustic startle response (ASR), adjusted for background noise [amplitude] ASR 89062 sound pressure level: 74dB 78dB 82dB 120dB

CC

18

both

9-11wks

N=7

2017

JaxCC1

acoustic startle test

(none)

average percent prepulse inhibition (PPI) evoked by 120 dB, adjusted for background noise [%] PPI 89071 prepulse stimulus: 74dB 78dB 82dB

CC

18

both

9-11wks

N=7

2017

JaxKOMP-EAP

hole board test

(none)

number of hole pokes by individual hole number, 20 min test [n] hole_pokes_by_hole total_hole_pokes_hole_N 100452 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

KOMP

1484

both

10wks

N=8

2021

JaxKOMP-EAP

ABR test

(none)

auditory brainstem response (ABR) threshold, sound pressure level [dB] ABR minimum_threshold 100501 6 kHz pip 12 kHz pip 18 kHz pip 24 kHz pip 30 kHz pip

KOMP

1739

both

10wks

N=4

2021

JaxKOMP-EAP

acoustic startle test

(none)

average startle response to pre-pulse [mV] avg_pp ppN_avg 100509 pp1 pp2 pp3

KOMP

1788

both

10wks

N=8

2021

JaxKOMP-EAP

acoustic startle test

(none)

average startle response to full pulse (120 dB) preceded by pre-pulse [mV] avg_pp_s ppN_s_avg 100510 pp1 pp2 pp3

KOMP

1788

both

10wks

N=8

2021

JaxKOMP-EAP

acoustic startle test

(none)

average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_ppi pct_ppi_ppN_avg 100517 pp1 pp2 pp3

KOMP

1788

both

10wks

N=8

2021

JaxKOMP-EAP

acoustic startle test

(none)

corrected average startle response to pre-pulse and full pulse (120 dB) minus average startle response to same pre-pulse [mV] avg_corrected_pp_s corrected_ppN_avg 100522 pp1 pp2 pp3

KOMP

1788

both

10wks

N=8

2021

JaxKOMP-EAP

acoustic startle test

(none)

corrected average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_corrected_ppi corrected_percent_ppN_avg 100526 74 dB 78 dB 82 dB

KOMP

1788

both

10wks

N=8

2021

JaxKOMP-EAP

acoustic startle test

(none)

maximum startle response to pre-pulse [mV] max_pp ppN 100533 pp1 pp2 pp3

KOMP

1788

both

10wks

N=8

2021

JaxKOMP-EAP

acoustic startle test

(none)

maximum startle response to full pulse (120 dB) preceded by pre-pulse [mV] max_pp_s ppN_s 100537 74 dB 78 dB 82 dB

KOMP

1788

both

10wks

N=8

2021

JaxKOMP-EAP

acoustic startle test

(none)

maximum percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] max_ppi pct_ppi_ppN 100540 pp2 pp3

KOMP

1788

both

10wks

N=8

2021

JaxKOMP-EAP

acoustic startle test

(none)

corrected maximum startle response to pre-pulse and full pulse (120 dB) minus maximum startle response to same pre-pulse [mV] max_corrected_pp_s corrected_ppN_vmax 100551 pp1 pp2 pp3

KOMP

1788

both

10wks

N=8

2021

JaxKOMP-EAP

acoustic startle test

(none)

corrected maximum percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] max_corrected_ppi corrected_percent_ppN_vmax 100555 pp1 pp2 pp3

KOMP

1788

both

10wks

N=8

2021

JaxKOMP-EAP

electroconvulsion test

(none)

applied stimulus (current), by day [mA] current ma 100783 day: 1 2 3 4 5 6 7 8 9 10

KOMP

23

both

17wks

N=8

2016

JaxKOMP-EAP

electroconvulsion test

(none)

behavior following applied stimulus (current), by day [score] score 100784 day: 1 2 3 4 5 6 7 8 9 10

KOMP

448

both

17wks

N=9

2016

JaxKOMP-LAP

hole board test

(none)

number of hole pokes by individual hole number, 20 min test [n] total_hole_pokes_hole_N 101452 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

KOMP

97

both

67-73wks

N=7

2021

JaxKOMP-LAP

acoustic startle test

(none)

average startle response to pre-pulse [mV] avg_pp ppN_avg 101509 pp1 pp2 pp3

KOMP

3

both

68-72wks

N=9

2018

JaxKOMP-LAP

acoustic startle test

(none)

average startle response to full pulse (120 dB) preceded by pre-pulse [mV] avg_pp_s ppN_s_avg 101510 pp1 pp2 pp3

KOMP

3

both

68-72wks

N=9

2018

JaxKOMP-LAP

acoustic startle test

(none)

average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_ppi pct_ppi_ppN_avg 101517 pp1 pp2 pp3

KOMP

3

both

68-72wks

N=9

2018

JaxKOMP-LAP

acoustic startle test

(none)

corrected average startle response to pre-pulse and full pulse (120 dB) minus average startle response to same pre-pulse [mV] avg_corrected_pp_s corrected_ppN_avg 101522 pp1 pp2 pp3

KOMP

3

both

68-72wks

N=9

2018

JaxKOMP-LAP

acoustic startle test

(none)

corrected average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_corrected_ppi corrected_percent_ppN_avg 101526 74 dB 78 dB 82 dB

KOMP

3

both

68-72wks

N=9

2018

JaxKOMP-LAP

acoustic startle test

(none)

maximum startle response to pre-pulse [mV] max_pp ppN 101533 pp1 pp2 pp3

KOMP

3

both

68-72wks

N=9

2018

JaxKOMP-LAP

acoustic startle test

(none)

maximum startle response to full pulse (120 dB) preceded by pre-pulse [mV] max_pp_s ppN_s 101537 74 dB 78 dB 82 dB

KOMP

3

both

68-72wks

N=9

2018

JaxKOMP-LAP

acoustic startle test

(none)

maximum percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] max_ppi pct_ppi_ppN 101540

KOMP

3

both

68-72wks

N=9

2018

JaxKOMP-LAP

acoustic startle test

(none)

corrected maximum startle response to pre-pulse and full pulse (120 dB) minus maximum startle response to same pre-pulse [mV] max_corrected_pp_s corrected_ppN_vmax 101551 pp1 pp2 pp3

KOMP

3

both

68-72wks

N=9

2018

JaxKOMP-LAP

acoustic startle test

(none)

corrected maximum percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] max_corrected_ppi corrected_percent_ppN_vmax 101555 pp1 pp2 pp3

KOMP

3

both

68-72wks

N=9

2018

JaxKOMP-LAP

ABR test

(none)

auditory brainstem response (ABR) threshold, sound pressure level [dB] pip minimum_threshold 101501 6 kHz pip 12 kHz pip 18 kHz pip 24 kHz pip 30 kHz pip

KOMP

both

74-78wks

N=4

2017

Jaxpheno8

ABR test

(none)

auditory brainstem response (ABR) threshold, sound pressure level [dB] ABR 35001 click 8kHz tone 16kHz tone 32kHz tone

inbred

7

m

10-13wks

N=9

2010

Jaxpheno8

echocardiography

(none)

interventricular septum thickness [mm] IVS 35017 diastolic systolic

inbred

6

m

12wks

N=5

2010

Jaxpheno8

echocardiography

(none)

left ventricle anterior wall thickness [mm] LV_AW 35019 diastolic systolic

inbred

6

m

12wks

N=5

2010

Jaxpheno8

echocardiography

(none)

left ventricle posterior wall thickness [mm] LV_PW 35021 diastolic systolic

inbred

6

m

12wks

N=5

2010

Jaxpheno8

echocardiography

(none)

left ventricle internal dimension [mm] LVID 35023 diastolic systolic

inbred

6

m

12wks

N=5

2010

Jaxpheno8

echocardiography

(none)

left ventricle volume [µL] LV_vol 35025 diastolic systolic

inbred

6

m

12wks

N=5

2010

Johnson1

ABR test

(none)

auditory brainstem response (ABR) threshold, 3-12 wk old group, sound pressure level [dB] pip_yng 1402 click 8kHz pip 16kHz pip 32kHz pip

inbred

42

both

3-12wks

N=7

2000

Johnson1

ABR test

(none)

auditory brainstem response (ABR) threshold, 15-72 wk old group, sound pressure level [dB] pip_old 1407 click 8kHz pip 16kHz pip 32kHz pip

inbred

27

both

15-72wks

N=12

2000

Johnson3

ABR test

(none)

auditory brainstem response (ABR) threshold, sound pressure level [dB] ABR 42501 click 8kHZ tone 16kHz tone 32kHz tone

B6.A consomic w/par

24

both

23-30wks

N=7

2012

Johnson4

ABR test

(none)

auditory brainstem response (ABR) threshold, sound pressure level [dB] ABR 42601 click 8kHZ tone 16kHz tone 32kHz tone

B6.PWD consomic w/par

28

both

49-63wks

N=8

2012

Kumar2

open field test

(none)

distance traveled, 55 min test [cm] distance 65001 first 10 min total

inbred

58

both

7-26wks

N=16

2019

Loos2

home cage monitoring

(none)

cumulative number of activity bouts, over 3 days of testing, log10 transformed [log(n)] activity_num 54001 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

mean duration per activity bout, over 3 days of testing, log10 transformed [log(s)] activity_mean_dur 54005 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

habituation ratio describing change in cumulative activity duration, over 3 days of testing, log10 transformed [log(ratio)] activity_dur_hab 54007 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

cumulative duration in spout zone, over 3 days of testing, log10 transformed [log(s)] spout_dur 54012

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

cumulative number of visits to OnShelter zone, over 3 days of testing, log10 transformed [log(n)] onshelter_num 54016 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

cumulative duration in OnShelter zone, over 3 days of testing, log10 transformed [log(s)] onshelter_dur 54018 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

change in activity proportion: anticipation of phase change, over 3 days of testing activity_anticipation 54022 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

change in activity proportion: response to phase onset, over 3 days of testing activity_response 54024 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

change in Spout zone duration: anticipation of phase change, over 3 days of testing spout_anticipation 54026 dark light

inbred w/CC7

11

m

8-12wks

N=35

2016

Loos2

home cage monitoring

(none)

change in Spout zone duration: response to phase onset, over 3 days of testing spout_response 54028 dark light

inbred w/CC7

11

m

8-12wks

N=36

2016

Loos2

home cage monitoring

(none)

change in Feeding zone duration: anticipation of phase change, over 3 days of testing feeding_anticipation 54032 dark light

inbred w/CC7

11

m

8-12wks

N=35

2016

Loos2

home cage monitoring

(none)

change in Feeding zone duration: response to phase onset, over 3 days of testing feeding_response 54034 dark light

inbred w/CC7

11

m

8-12wks

N=36

2016

Loos2

home cage monitoring

(none)

change in OnShelter zone duration: anticipation of phase change, over 3 days of testing onshelter_anticipation 54036 dark light

inbred w/CC7

11

m

8-12wks

N=35

2016

Loos2

home cage monitoring

(none)

change in OnShelter zone duration: response to phase onset, over 3 days of testing onshelter_response 54038 dark light

inbred w/CC7

11

m

8-12wks

N=36

2016

Loos2

home cage monitoring

(none)

cumulative long movement number, over 3 days of testing, log10 transformed [log(n)] long_move_num 54042 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

cumulative long movement distance, over 3 days of testing, log10 transformed [log(cm)] long_move_dist 54044 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

cumulative short movement number, over 3 days of testing, log10 transformed [log(n)] short_move_num 54048 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

cumulative short movement distance, over 3 days of testing, log10 transformed [log(cm)] short_move_dist 54052 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

cumulative number of long arrests, over 3 days of testing, log10 transformed [log(n)] long_arrest_num 54054 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

mean duration per long arrest, over 3 days of testing, log10 transformed [log(s)] long_arrest_dur_mean 54058 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

cumulative number of short arrests, over 3 days of testing, log10 transformed [log(n)] short_arrest_num 54063 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

mean duration per short arrest, over 3 days of testing, log10 transformed [log(s)] short_arrest_dur_mean 54067 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

cumulative number of long shelter visits (sheltering), over 3 days of testing, log10 transformed [log(n)] long_shelter_num 54071 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

cumulative duration of long shelter visits (sheltering), over 3 days of testing [s] long_shelter_dur 54073 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

cumulative number of short shelter visits (sheltering), over 3 days of testing, log10 transformed [log(n)] short_shelter_num 54077 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Molenhuis1

monitoring system

(none)

social discrimination capacity (preference for novel versus familiar conspecific mouse) [ratio] discrimination 110069 short term discrimination long term discrimination

CC

49

m

7-20wks

N=4

2018

Petryshen1

acoustic startle test

(none)

acoustic startle response (ASR) without prepulse stimulus presented [N] ASR nostim 34701 no tone 120dB tone

B6.A consomic

22

m

7-9wks

N=23

2009

Petryshen1

acoustic startle test

(none)

acoustic startle response (ASR) evoked by 120 dB tone [N] ASR 34703 70dB 75dB 80dB 85dB

B6.A consomic

22

m

7-9wks

N=23

2009

Petryshen1

acoustic startle test

(none)

percent prepulse inhibition (PPI) evoked by 120 dB tone [%] PPI 34707 70dB 75dB 80dB 85dB

B6.A consomic

22

m

7-9wks

N=23

2009

Seburn1

monitoring system

(none)

oxygen volume, 3 day test [mL/kg/h] VO2 9208 daily light dark

inbred

16

both

7-9wks

N=8

2001

Seburn1

monitoring system

(none)

carbon dioxide volume, 3 day test [mL/kg/h] VCO2 9211 daily light dark

inbred

16

both

7-9wks

N=8

2001

Seburn1

monitoring system

(none)

respiratory exchange ratio, 3 day test [ratio] RER 9214 daily light dark

inbred

16

both

7-9wks

N=8

2001

Seburn1

monitoring system

(none)

body heat production, 3 day test [kcal/h] heat 9217 daily light dark

inbred

16

both

7-9wks

N=8

2001

Seburn1

monitoring system

(none)

total activity, beam breaks per min, 3 day test [n/min] tot 9223 daily light dark

inbred

16

both

7-9wks

N=8

2001

Seburn1

monitoring system

(none)

ambulatory activity, beam breaks per min, 3 day test [n/min] aa 9226 daily light dark

inbred

16

both

7-9wks

N=8

2001

Seburn1

monitoring system

(none)

rearing activity, beam breaks per min, 3 day test [n/min] ra 9229 daily light dark

inbred

16

both

7-9wks

N=8

2001

Spijker1

acoustic startle test

(none)

acoustic startle response (ASR) [amplitude] ASR 40601 65dB 70dB 75dB 80dB 90dB 100dB 110dB 120dB

BXD w/par

39

m

8wks

N=11

2011

Spijker1

acoustic startle test

(none)

prepulse inhibition (PPI), 120 dB startle intensity [%] PPI 40613 120 dB startle intensity with prepulse stimulus: 65dB 70dB 75dB 80dB

BXD w/par

36

m

8wks

N=9

2011

Tordoff1

bottle choice test

(none)

preference for NaCl (sodium chloride) solutions [%] NaCl_pref 6103 concentration (mM): 75 150 300 450

inbred

28

m

4-12wks

N=11

2001

Tordoff1

bottle choice test

(none)

preference for KCl (potassium chloride) solutions [%] KCl_pref 6109 concentration (mM): 10 30 100 200 300

inbred

28

m

4-12wks

N=12

2001

Tordoff1

bottle choice test

(none)

preference for CaCl2 (calcium chloride) solutions [%] CaCl2_pref 6116 concentration (mM): 3 10 30 100

inbred

28

m

4-12wks

N=11

2001

Tordoff1

bottle choice test

(none)

preference for NH4Cl (ammonium chloride) solutions [%] NH4Cl_pref 6122 concentration (mM): 10 30 100 300

inbred

28

m

4-12wks

N=11

2001

Tordoff3

body weight

(none)

body weight [g] bw 10305 start end fold change

inbred w/CC7

40

both

8-10wks

N=10

2002

Tordoff3

bottle choice test

(none)

preference for CaCl2 (calcium chloride) solutions [%] CaCl2_pref 10308 concentration (mM): 7.5 25 75

inbred w/CC7

40

both

9-11wks

N=10

2002

Tordoff3

bottle choice test

(none)

preference for CaLa (calcium lactate) solutions [%] CaLa_pref 10311 concentration (mM): 7.5 25 75

inbred w/CC7

40

both

10-12wks

N=10

2002

Tordoff3

bottle choice test

(none)

preference for NaCl (sodium chloride) solutions [%] NaCl_pref 10314 concentration (mM): 25 75 225

inbred w/CC7

40

both

11-13wks

N=10

2002

Tordoff3

bottle choice test

(none)

preference for NaLa (sodium lactate) solutions [%] NaLa_pref 10317 concentration (mM): 25 75 225

inbred w/CC7

40

both

12-14wks

N=10

2002

Trullas1

open field test

(none)

distance traveled, 5 min test [cm] OF_dist 52821 dim lights bright lights ratio

inbred

10

m

6-8wks

N=8

1993

Trullas1

open field test

(none)

amount of time moving horizontally, 5 min test [s] OF_horiz 52822 dim lights bright lights ratio

inbred

10

m

6-8wks

N=8

1993

Trullas1

open field test

(none)

number of times rearing, 5 min test [n] OF_rear 52823 dim lights bright lights ratio

inbred

10

m

6-8wks

N=8

1993

Willott1

acoustic startle test

(none)

acoustic startle response (ASR) [amplitude] ASR 9102 sound pressure level: 70dB 80dB 90dB 100dB

inbred w/CC7

40

both

5-6wks

N=10

2002

Willott1

acoustic startle test

(none)

mean prepulse inhibition (PPI), 70dB [ratio] PPI 9108 4kHz 12kHz 20kHz all tones

inbred w/CC7

40

both

5-6wks

N=10

2002

Xenakis2

intake monitoring

arsenic

water consumption [g] water 118335 iAs: 4 to 2 wks before 2 wks before to start start to 1 wk after 1 to 2 wks after (12 more)...

DO population

m

4-34wks

N=74

2022

Xenakis2

MRI

arsenic

weight of fat tissue [g] fat_wt 118351 iAs: 2 wks before 12 wks after 24 wks after

DO population

m

6-32wks

N=74

2022

Xenakis2

urinalysis

arsenic

urine volume, 2 wks before iAs [μL] urine_2wksBef 118363 attempt: 1st 2nd 3rd

DO population

m

6wks

N=45

2022

Xenakis2

urinalysis

arsenic

urine volume, 12 wks after iAs [μL] urine_12wks 118366 attempt: 1st 2nd 3rd

DO population

m

20wks

N=25

2022

Zimmermann1

intake monitoring

(none)

food consumption, second day [g] food_intake 112168 during light during dark

inbred

30

both

7-15wks

N=11

2020

Zimmermann1

intake monitoring

(none)

water consumption, second day [mL] water_intake 112170 during light during dark

inbred

30

both

7-15wks

N=11

2020

Zimmermann1

monitoring system

(none)

fine or stationary movement on x-y axis, repeated interruptions of same beam, second day (beam breaks/min) [n/min] fine_act 112172 during light during dark

inbred

30

both

7-15wks

N=11

2020

Zimmermann1

monitoring system

(none)

ambulatory movement on x-y axis, consecutive interruptions of different beams, second day (beam breaks/min) [n/min] amb_act 112174 during light during dark

inbred

30

both

7-15wks

N=11

2020

Zimmermann1

monitoring system

(none)

rearing movement, number of z-axis beam breaks, second day (beam breaks/min) [n/min] rearing_act 112176 during light during dark

inbred

30

both

7-15wks

N=11

2020

Zimmermann1

monitoring system

(none)

respiratory exchange ratio (VCO2:VO2), second day [ratio] rer 112178 during light during dark

inbred

30

both

7-15wks

N=11

2020

Zimmermann1

monitoring system

(none)

volume of oxygen consumed, second day [mL/h] vo2 112180 during light during dark

inbred

30

both

7-15wks

N=11

2020

Zimmermann1

monitoring system

(none)

volume of carbon dioxide produced, second day [mL/h] vco2 112182 during light during dark

inbred

30

both

7-15wks

N=11

2020

Zimmermann1

monitoring system

(none)

energy expenditure, second day [kcal/h] energy 112184 during light during dark

inbred

30

both

7-15wks

N=11

2020

Study designs: all MPD measure sets of study design type series

Filter Table Results